Showing results (171-180 of 181) with videos related to
Sort By:
Pageof 19
NPJ Breast Cancer|May 25, 2021
Anti-tumor effects of an ID antagonist with no observed acquired resistancePaulina M Wojnarowicz, Marta Garcia Escolano, Yun-Han Huang, et al.Nature Communications|October 21, 2018
HSP90-incorporating chaperome networks as biosensor for disease-related pathways in patient-specific midbrain dopamine neuronsSarah Kishinevsky, Tai Wang, Anna Rodina, et al.Nature Communications|January 13, 2021
Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesisTeng Gao, Ryan Ptashkin, Kelly L Bolton, et al.Neurology|November 14, 2024
Patterns and Clinical Implications of Hemorrhagic Transformation After Thrombolysis in Acute Ischemic Stroke: Results From the ENCHANTED StudyYanan Wang, Toshiki Maeda, Shoujiang You, et al.Journal of the American Medical Informatics Association : JAMIA|July 14, 2021
Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical centerPeter J Schüffler, Luke Geneslaw, D Vijay K Yarlagadda, et al.Cell Reports|October 3, 2019
A Small-Molecule Pan-Id Antagonist Inhibits Pathologic Ocular NeovascularizationPaulina M Wojnarowicz, Raquel Lima E Silva, Masayuki Ohnaka, et al.The New England Journal of Medicine|March 23, 2017
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 InhibitorHilary Longhurst, Marco Cicardi, Timothy Craig, et al.Nature Genetics|October 27, 2020
Cancer therapy shapes the fitness landscape of clonal hematopoiesisKelly L Bolton, Ryan N Ptashkin, Teng Gao, et al.Cancer Research|September 5, 2023
Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortalIno de Bruijn, Ritika Kundra, Brooke Mastrogiacomo, et al.Nature|November 12, 2020
Dense sampling of bird diversity increases power of comparative genomicsShaohong Feng, Josefin Stiller, Yuan Deng, et al.Pageof 19